$11.64
-0.130 (-1.10%)
At Close: Jun 23, 2026
Core Laboratories (NYSE:CLB) Shares Cross Above Two Hundred Day Moving Average – Time to Sell?
02:33am, Friday, 13'th Mar 2026
Core Laboratories Inc. (NYSE: CLB - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $15.60 and traded as h
DTI or CLB: Which Is the Better Value Stock Right Now?
12:42pm, Wednesday, 11'th Mar 2026
Investors interested in Oil and Gas - Field Services stocks are likely familiar with Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two stocks presents invest
Why Is Core Laboratories (CLB) Down 14.2% Since Last Earnings Report?
12:32pm, Friday, 06'th Mar 2026
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Core Labs Jumps 79% in 6 Months: Time to Buy or Stay on the Sidelines?
09:40am, Wednesday, 18'th Feb 2026
CLB shows strong international demand, free cash flow generation and a solid financial position, but near-term U.S. land activity challenges and margin pressure could limit growth.
Core Laboratories Q4 Earnings Call Highlights
01:02am, Sunday, 08'th Feb 2026
Core Laboratories (NYSE: CLB) reported fourth-quarter and full-year 2025 results that reflected modest top-line growth, continued shareholder returns, and a mix of strength in international demand alo
Core Laboratories Q4 Earnings Beat Estimates, Expenses Increase Y/Y
10:06am, Friday, 06'th Feb 2026
CLB expects revenues to range from $124 million to $130 million and earnings per share to be between 11 cents and 15 cents for the first quarter of 2026.
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
04:14pm, Thursday, 05'th Feb 2026
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
Core Laboratories (CLB) Beats Q4 Earnings and Revenue Estimates
07:41pm, Wednesday, 04'th Feb 2026
Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.22 per share a year ago.
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS
05:15pm, Wednesday, 04'th Feb 2026
FOURTH QUARTER REVENUE OF $138.3 MILLION, UP 3% SEQUENTIALLY AND UP 7% YEAR-OVER-YEAR FOURTH QUARTER OPERATING INCOME OF $15.8 MILLION; EX-ITEMS, $15.7
What's in Store for Core Laboratories Stock in Q4 Earnings?
09:05am, Thursday, 29'th Jan 2026
CLB is expected to report higher revenues than the year-ago period's level. However, it is expected to have faced increased costs and expenses.
HAL vs. CLB: Which Stock Is the Better Value Option?
12:40pm, Tuesday, 27'th Jan 2026
Investors interested in Oil and Gas - Field Services stocks are likely familiar with Halliburton (HAL) and Core Laboratories (CLB). But which of these two companies is the best option for those lookin
Arkadios Wealth Advisors Has $609,000 Stake in Core Laboratories Inc. $CLB
03:19am, Tuesday, 27'th Jan 2026
Arkadios Wealth Advisors reduced its holdings in Core Laboratories Inc. (NYSE: CLB) by 41.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commissi
Core Laboratories Stock's Stability Makes It a Wise Hold for Now
10:11am, Tuesday, 06'th Jan 2026
CLB shows consistent growth, a strong market position and proprietary tech, but faces challenges like cost pressure, international risks and high valuation concerns.
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
04:05pm, Monday, 05'th Jan 2026
HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2025 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on February 5, 2026.
Ariel Investments LLC Has $149.49 Million Stock Position in Core Laboratories Inc. $CLB
03:28am, Wednesday, 10'th Dec 2025
Ariel Investments LLC lifted its position in shares of Core Laboratories Inc. (NYSE: CLB) by 25.5% in the second quarter, according to the company in its most recent disclosure with the Securities and
Sign In
Buy CLB